Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.59 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.59 |
| ▸ | TP53 | P04637 | 1/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.59 |
| ▸ | TSHR | P16473 | 1/20 | 0.59 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.59 |
| ▸ | IDO1 | P14902 | 5/20 | 0.50 |
| ▸ | AGXT | P21549 | 2/20 | 0.50 |
| ▸ | CA12 | O43570 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | CA7 | P43166 | 1/20 | 0.46 |
| ▸ | CA9 | Q16790 | 1/20 | 0.46 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.46 |
| ▸ | LTA4H | P09960 | 1/20 | 0.45 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.45 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.42 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7921584 | 0.88 | ALDH1A1 (0.59) | ALDH1A1ALOX15TP53CYP3A4TSHR | |
| SCHEMBL11437812 | 0.87 | ALDH1A1 (0.68) | ALDH1A1ALOX15TP53CYP3A4TSHR | |
| SCHEMBL5021267 | 0.81 | TP53 (0.37) | ALDH1A1ALOX15TP53CYP3A4TSHR | |
| SCHEMBL12924871 | 0.81 | ALDH1A1 (0.61) | ALDH1A1ALOX15TP53CYP3A4TSHR | |
| SCHEMBL5002160 | 0.81 | ALDH1A1 (0.61) | ALDH1A1ALOX15TP53CYP3A4TSHR | |
| SCHEMBL1781780 | 0.81 | AGXT (0.45) | ALDH1A1ALOX15TP53CYP3A4TSHR | |
| SCHEMBL1784538 | 0.81 | TP53 (0.37) | ALDH1A1ALOX15TP53CYP3A4TSHR | |
| SCHEMBL5021265 | 0.81 | AGXT (0.45) | ALDH1A1ALOX15TP53CYP3A4TSHR | |
| SCHEMBL6665182 | 0.80 | LTA4H (0.52) | ALDH1A1ALOX15TP53CYP3A4TSHR | |
| SCHEMBL16093275 | 0.79 | ACHE (0.62) | ALDH1A1ALOX15TP53CYP3A4TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4138411-A | RUTHENIUM OR OSMIUM CATALYST | RHONE-POULENC S. A. (FR) | 1979-02-06 | — | — | US | claimed |
| US-12441669-B2 | PCNHCP metal complexes and uses thereof | TECHNION RESEARCH & DEVELOPMENT FOUNDATION LTD. (IL) | 2025-10-14 | — | — | US | disclosed |
| CN-119528960-A | Method for preparing allylsilane compound through enol ether double bond displacement | 成都泰和伟业生物科技有限公司 | 2025-02-28 | — | — | CN | disclosed |
| US-20230322647-A1 | PCNHCP METAL COMPLEXES AND USES THEREOF | TECHNION RESEARCH & DEVELOPMENT FOUNDATION LTD. (IL) | 2023-10-12 | — | — | US | disclosed |
| WO-2022229784-A1 | MIXTURES OF EMULSIFIED TERPENES HAVING ANTIBACTERIAL AND ANTIFUNGAL ACTIVITY | VILLAGOMEZ DIAZ, Jennifer Paulina (EC) | 2022-11-03 | — | — | WO | disclosed |
| WO-2022043993-A1 | PCNHCP METAL COMPLEXES AND USES THEREOF | TECHNION RESEARCH & DEVELOPMENT FOUNDATION LTD. (IL) | 2022-03-03 | — | — | WO | disclosed |
| US-9572850-B2 | Use of cajeput and Pimenta racemosa extract for treating parasitic infestation of fish | MARS, INCORPORATED (US) | 2017-02-21 | — | — | US | disclosed |
| EP-2461698-B1 | USE OF CAJEPUT AND PIMENTA RACEMOSA EXTRACT FOR TREATING PARASITIC INFESTATION OF FISH | MARS INC (US) | 2013-02-13 | — | — | EP | disclosed |
| US-20120276227-A1 | USE OF CAJEPUT AND PIMENTA RACEMOSA EXTRACT FOR TREATING PARASITIC INFESTATION OF FISH | MARS, INCORPORATED (US) | 2012-11-01 | — | — | US | disclosed |
| EP-2461698-A1 | USE OF CAJEPUT AND PIMENTA RACEMOSA EXTRACT FOR TREATING PARASITIC INFESTATION OF FISH | Mars, Incorporated (US) | 2012-06-13 | — | — | EP | disclosed |
| EP-1363650-B1 | COMPOSITION CONTAINING PIMENTA EXTRACT IN AQUATIC ANIMAL TREATMENT METHODS | AQUARIUM PHARMA (US) | 2007-09-26 | — | — | EP | disclosed |
| EP-1363650-A2 | AQUATIC ANIMAL TREATMENT METHOD AND COMPOSITION CONTAINING i PIMENTA /i EXTRACT | Aquarium Pharmaceuticals Inc. (US) | 2003-11-26 | — | — | EP | disclosed |
| US-6537591-B2 | Administering plant extract | AQUARIUM PHARMACEUTICALS, INC. | 2003-03-25 | — | — | US | disclosed |
| US-20020164384-A1 | Aquatic animal treatment method and composition containing pimenta extract | AQUARIUM PHARMACEUTICALS, INC. (US) | 2002-11-07 | — | — | US | disclosed |
| WO-2002069989-A2 | AQUATIC ANIMAL TREATMENT METHOD AND COMPOSITION CONTAINING PIMENTA EXTRACT | AQUARIUM PHARMACEUTICALS, INC. (US) | 2002-09-12 | — | — | WO | disclosed |
| US-5173535-A | PLASTICS CONTAINING SUSTAINED RELEASE OF FUNCTIONAL MATERIALS | DOW CORNING CORPORATION (US) | 1992-12-22 | — | — | US | disclosed |
| EP-0328145-A2 | Plastics containing discrete particles with functional materials | DOW CORNING CORPORATION (US) | 1989-08-16 | — | — | EP | disclosed |
| US-4138411-A | RUTHENIUM OR OSMIUM CATALYST | RHONE-POULENC S. A. (FR) | 1979-02-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230322647-A1 | PCNHCP METAL COMPLEXES AND USES THEREOF | PIN4, HIRIP3, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 | ALDH1A1 4332/4885ALOX15 3549/4885TP53 3315/4885 |
| US-12441669-B2 | PCNHCP metal complexes and uses thereof | PIN4, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, HIRIP3 | ALDH1A1 4345/4885ALOX15 3327/4885TP53 3569/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.